Clinical Trials on Epithelial Ovarian Cancer in Australia
Total 2419 results
-
Verastem, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingLow Grade Serous Ovarian CancerUnited States, United Kingdom, Australia
-
MorphotekTerminatedOvarian CancerCanada, United States, Netherlands, Spain, Belgium, Australia
-
Medical University InnsbruckUnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerAustria
-
ImmVirx Pty LtdRecruitingColorectal Cancer | Ovarian Cancer | Gastroesophageal CancerAustralia
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada, United Kingdom, Australia
-
AGO Study GroupArbeitsgemeinschaft Gynaekologische Onkologie Austria; MITOCompletedOvarian CancerGermany, Belgium, Italy, Austria
-
AstraZenecaCompletedOvarian NeoplasmsSpain, United States, Belgium, United Kingdom, Israel, Poland, Germany, Sweden, Australia
-
European Organisation for Research and Treatment...CompletedOvarian CancerFrance, United Kingdom, Spain, Austria
-
Medical Research CouncilEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerSpain, Belgium, France, Netherlands, Austria, United Kingdom, Italy, South Africa, Portugal, Ireland
-
zr Pharma & GmbHFoundation Medicine; Myriad Genetics, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Spain, Canada, Australia, United Kingdom, France
-
Eli Lilly and CompanyCompletedOvarian CancerUnited States, Israel, Spain, Korea, Republic of, Australia, Belgium, United Kingdom, Italy
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
Impact Therapeutics, Inc.CompletedBreast Cancer | Ovarian Cancer | Prostate Cancer | Primary Peritoneal Cancer | Advanced Solid TumoursAustralia
-
Mersana TherapeuticsGOG Foundation; European Network of Gynaecological Oncological Trial Groups...TerminatedUpifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) (UP-NEXT)Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Ovarian CancerUnited States, Australia, Canada
-
PfizerTerminatedOvarian CancerKorea, Republic of, United States, Singapore, Taiwan, Japan, Italy, Australia, Belgium, Ireland, Russian Federation
-
Gynecologic Oncology GroupBristol-Myers Squibb; National Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Norway, Canada, Australia, Japan
-
AbbVie (prior sponsor, Abbott)CompletedOvarian CancerUnited States, Australia, Canada, Hungary, Israel, New Zealand, Poland, United Kingdom
-
PfizerTerminatedLow-grade Serous Ovarian Cancer | Low-grade Serous Fallopian Tube Cancer | Low-grade Serous Peritoneal CancerUnited States, Canada, Hungary, Spain, Belgium, France, United Kingdom, Australia, Czechia, Netherlands, Sweden, Italy, Denmark, Germany, Austria, Finland, Ireland, Norway, Poland
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
AmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, Belgium, Germany, Italy, United Kingdom, Canada, Denmark, Switzerland, Hong Kong, Austria, Slovakia, Taiwan, Hungary, France, Singapore, Australia, Poland, New Zealand
-
zr Pharma & GmbHFoundation Medicine; Myriad Genetics, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Spain, Belgium, Australia, Israel, Germany, France, United Kingdom, Italy, Canada, New Zealand
-
AGO Research GmbHARCAGY/ GINECO GROUP; Australia New Zealand Gynaecological Oncology Group; Arbeitsgemeinschaft... and other collaboratorsCompletedRecurrent Platinum-sensitive Ovarian CancerFrance, Belgium, Germany, Australia, United Kingdom, Austria
-
Hoffmann-La RocheCompletedBreast Cancer | Ovarian Cancer | Prostate CancerUnited States, Korea, Republic of, Italy, Australia, Spain
-
MEI Pharma, Inc.CompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States, Spain, Belgium, United Kingdom, Australia, Italy, Poland
-
Medical University of ViennaCompletedBreast Cancer | Hereditary Breast and Ovarian Cancer SyndromeAustria
-
Regeneron PharmaceuticalsRecruitingRecurrent Endometrial Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Italy, United Kingdom, Netherlands, Belgium, Australia, France, Israel
-
Universitaire Ziekenhuizen KU LeuvenEuropean CommissionCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaGermany, Belgium, Italy, Austria, France
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
AmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Austria, Belgium, Italy, Netherlands, Spain, Canada, Denmark, Germany, Korea, Republic of, Russian Federation, Hong Kong, Greece, Japan
-
Johnson & Johnson Pharmaceutical Research & Development...PharmaMarCompletedOvarian CancerUnited States, France, Poland, United Kingdom, China, Belgium, Germany, Hong Kong, Taiwan, Spain, Canada, Netherlands, Sweden, Korea, Republic of, Singapore, Russian Federation, Argentina, Brazil, Chile, Australia
-
Hoffmann-La RocheCompletedOvarian CancerItaly, Austria, Belgium, France, Germany, Spain, Netherlands, Sweden, Denmark, Norway
-
ppharmaand GmbHBristol-Myers Squibb; Gynecologic Oncology Group; European Network of Gynaecological... and other collaboratorsActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete ResponseUnited States, United Kingdom, Korea, Republic of, Russian Federation, Canada, Denmark, Taiwan, New Zealand, Ireland, Japan, Spain, Australia, Israel, Italy, Greece, Sweden, Czechia, Finland, Poland, Belgium, Germany, Romania, Singa... and more
-
Arcagy ResearchBelgian Gynaecological Oncology Group; Grupo Español de Investigación en Cáncer... and other collaboratorsCompletedOvarian CancerFrance, Germany, Austria, Denmark, Italy, Japan, Finland, Spain, Monaco, Sweden, Belgium
-
AGO Study GroupActive, not recruitingOvarian CancerUnited States, France, Germany, Austria, Sweden, Denmark, Italy, United Kingdom
-
Incyte CorporationTerminatedOvarian Cancer | Genitourinary (GU) TumorsUkraine, United Kingdom, United States, Australia, Canada, Russian Federation
-
MorphotekEisai Europe Ltd. (United Kingdom)TerminatedOvarian CancerUnited States, Hong Kong, Netherlands, Spain, Korea, Republic of, Belgium, Taiwan, Israel, Japan, France, United Kingdom, Singapore, Italy, Argentina, India, Germany, Hungary, Australia, Portugal, Russian Federation, Canada, Poland, Greec... and more
-
Mario Negri Institute for Pharmacological ResearchPharmaMar; Averion International CorporationCompletedOvarian CancerAustria, Belgium, Norway, Spain, Finland, United Kingdom, Italy, Denmark, Germany, Netherlands, Switzerland
-
Novartis PharmaceuticalsActive, not recruitingOvarian CancerUnited States, Italy, United Kingdom, Malaysia, Taiwan, Turkey, Belgium, Canada, Spain, Singapore, Austria, Denmark, Korea, Republic of, Australia, China, France, Netherlands, Russian Federation, Germany, Argentina, Mexico, Finland, Portuga... and more
-
ExelixisRecruitingCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Spain, Australia, Belgium, France, Italy, Netherlands, United Kingdom, Korea, Republic of
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Sweden, Hong Kong, Canada, Switzerland, Estonia, Greece, Russian Federation, Hungary, Austria, Bulgaria, Netherlands, Latvia, Italy, Slovenia, Turkey, Serbia, Israel, Argentina, Brazil, Slovakia, Lithuania, Poland, Portugal, Mexi... and more
-
Kazia Therapeutics LimitedCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States, Australia
-
AGO Study GroupCancer Research UK; ARCAGY/ GINECO GROUP; Grupo Español de Investigación en Cáncer... and other collaboratorsCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerSpain, France, Denmark, Belgium, Germany, Austria, China, Italy, Korea, Republic of, Norway, Sweden, United Kingdom
-
AstraZenecaEuropean Network of Gynaecological Oncological Trial Groups (ENGOT); Myriad... and other collaboratorsActive, not recruitingAdvanced Ovarian CancerCanada, Denmark, Germany, Italy, Spain, United States, Belgium, Poland, France, Korea, Republic of, Brazil, Hungary, Japan, Peru, Turkey, China, Austria, Bulgaria, Finland, Romania
-
Ferring PharmaceuticalsCompletedControlled Ovarian StimulationAustralia, Austria, Belgium, Canada, Germany, Italy, Netherlands, Poland, Spain, United Kingdom
-
AGO Research GmbHHoffmann-La RocheActive, not recruitingRecurrent Ovarian CarcinomaNorway, Spain, France, Switzerland, Denmark, Germany, Sweden, Belgium, Finland, Austria, Estonia, Lithuania
-
AstraZenecaCompletedOvarian CancerCanada, Czechia, Poland, Romania, United States, Belgium, France, Russian Federation, United Kingdom, Israel, Spain, Germany, Austria, Netherlands, Australia, Estonia, Ukraine
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
AstraZenecaCompletedOvarian NeoplasmsAustralia, Korea, Republic of, Taiwan
-
Venn Biosciences CorporationCompletedOvarian Cancer | Adnexal Mass | Pelvic MassPhilippines, United States, Malaysia, Australia